Maplight Therapeutics, Inc. · NASDAQ:MPLT
Forbion Growth Opportunities Fund III Cooperatief U.A. reported a 7.10% stake in Maplight Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 17, 2026
Forbion Growth Opportunities Fund III Cooperatief U.A. reported a 7.10% stake in Maplight Therapeutics, Inc., 3,226,400 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 7.10%
- Shares
- 3,226,400
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 7.10% | 3,226,400 |
| Forbion Growth III Management B.V. | 7.10% | 3,226,400 |
Source
Related
- Maplight Therapeutics, Inc.
- Forbion Growth Opportunities Fund III Cooperatief U.A.
- Maplight Therapeutics, Inc. shareholders
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Oct 16, 2026